Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C MacDougall

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Platelets|November 4, 2010
Original articles: increased platelet volume in patients with adult polycystic kidney diseaseP M Bath, A K Saggar-Malik, I C Macdougall, et al.
British Journal of Urology|October 1, 1995
Prostate-specific antigen levels in patients receiving long-term dialysisL Harper, C W McIntyre, I C MacDougall, et al.
Kidney International|November 1, 1996
A randomized controlled study of iron supplementation in patients treated with erythropoietinI C Macdougall, B Tucker, J Thompson, et al.
Journal of the American Society of Nephrology : JASN|November 30, 1999
Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patientsI C Macdougall, S J Gray, O Elston, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 6-8: assessing and optimizing iron storesI C Macdougall, W H Hörl, C Jacobs, et al.
Contributions to Nephrology|January 1, 1989
Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patientsI C Macdougall, I Cavill, M E Davies, et al.
Contributions to Nephrology|January 1, 1989
Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatmentI C Macdougall, D E Roberts, P Neubert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 17-18: adverse effectsW H Hörl, C Jacobs, I C Macdougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 1-4: evaluating anaemia and initiating treatmentF Valderrábano, W H Hörl, C Jacobs, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 9-13: anaemia managementC Jacobs, W H Hörl, I C Macdougall, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Platelets|November 4, 2010
Original articles: increased platelet volume in patients with adult polycystic kidney diseaseP M Bath, A K Saggar-Malik, I C Macdougall, et al.
British Journal of Urology|October 1, 1995
Prostate-specific antigen levels in patients receiving long-term dialysisL Harper, C W McIntyre, I C MacDougall, et al.
Kidney International|November 1, 1996
A randomized controlled study of iron supplementation in patients treated with erythropoietinI C Macdougall, B Tucker, J Thompson, et al.
Journal of the American Society of Nephrology : JASN|November 30, 1999
Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patientsI C Macdougall, S J Gray, O Elston, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 6-8: assessing and optimizing iron storesI C Macdougall, W H Hörl, C Jacobs, et al.
Contributions to Nephrology|January 1, 1989
Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patientsI C Macdougall, I Cavill, M E Davies, et al.
Contributions to Nephrology|January 1, 1989
Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatmentI C Macdougall, D E Roberts, P Neubert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 17-18: adverse effectsW H Hörl, C Jacobs, I C Macdougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 1-4: evaluating anaemia and initiating treatmentF Valderrábano, W H Hörl, C Jacobs, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 9-13: anaemia managementC Jacobs, W H Hörl, I C Macdougall, et al.
Pageof 10